Clinical Trials Directory

Trials / Completed

CompletedNCT03329456

MEV to Block the Posterior and Lateral Cords of the Infraclavicular Brachial Plexus

Minimum Effective Volume (MEV95%) of Ropivacaine 7.5 mg/ml to Block the Posterior and Lateral Cords of the Infraclavicular Brachial Plexus

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
23 (actual)
Sponsor
University Hospital of North Norway · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The investigators have recently shown that LSIB in combination with a suprascapular and a cervical plexus block is a very good alternative for arthroscopic shoulder surgery. However, the investigators believe the total volume of local anesthetic for LSIB may be reduced. For shoulder surgery there is no need to block the medial cord and the investigators therefore hypothesize a significantly lower MEV95% by applying a selective lateral and posterior cord block

Detailed description

The MEV for a successful block in 50% of the participants will be determined by using the staircase up-and-down method introduced by Dixon and Massey. Logistic regression and probit transformation will be applied to estimate the MEV for a successful block in 95% of the participants.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaineMinimum effective volume

Timeline

Start date
2017-10-30
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2017-11-06
Last updated
2019-01-29

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT03329456. Inclusion in this directory is not an endorsement.